Form S-8 - Securities to be offered to employees in employee benefit plans:
SEC Accession No. 0000950170-24-038022
Filing Date
2024-03-28
Accepted
2024-03-28 16:05:53
Documents
4
Effectiveness Date
2024-03-28

Document Format Files

Seq Description Document Type Size
1 S-8 rphm_2024_s-8_2021_eip.htm S-8 117515
2 EX-5.1 rphm-ex5_1.htm EX-5.1 18073
3 EX-23.1 rphm-ex23_1.htm EX-23.1 2988
4 EX-FILING FEES rphm-exfiling_fees.htm EX-FILING FEES 45596
  Complete submission text file 0000950170-24-038022.txt   185237
Mailing Address 18575 JAMBOREE ROAD SUITE 275-S IRVINE CA 92612
Business Address 18575 JAMBOREE ROAD SUITE 275-S IRVINE CA 92612 (858) 283-0280
Reneo Pharmaceuticals, Inc. (Filer) CIK: 0001637715 (see all company filings)

EIN.: 472309515 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-8 | Act: 33 | File No.: 333-278315 | Film No.: 24798817
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)